Bone Biologics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -765 | -677 | 48 |
EBIT | -677 | -666 | |
Net Income | -765 | -684 | -666 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -804 | -714 | -591 |
Cash | 4,530 | 5,334 | 6,049 |
Basic Shares | 1,795 | 1,174 | 1,795 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | 0 | ||
EBITDA | -3,108 | 107 | 479 | -752 |
EBIT | -4,112 | -8,948 | -8,062 | |
Net Income | -3,108 | -4,112 | -8,949 | -1,484 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,691 | -4,124 | -9,555 | -3,566 |
Cash | 5,334 | 3,325 | 3,026 | 7,538 |
Basic Shares | 1,174 | 1,517 | 263 | 47 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.43 |
2026-03-31 | -$0.43 |
2025-12-31 | -$0.63 |
2025-09-30 | -$0.37 |